Henry E. Pelish, Chief Scientific Officer at Nuvalent, Inc. (NUVL), sold 200 shares at $79.82 ($16K) on 2025-06-06, disclosed to the SEC on 2025-06-10.
Scheduled sale ($16k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NUVL | SELL | 2026-03-16 | $3.4M | — | Filing → |
| NUVL | SELL | 2026-01-07 | $502K | — | Filing → |
| NUVL | SELL | 2025-10-17 | $2.6M | — | Filing → |